Works matching IS 23744677 AND DT 2023 AND VI 9 AND IP 1

Results: 105

Post-diagnosis weight trajectories and mortality among women with breast cancer.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00603-5

By:

Puklin, Leah S.;
Li, Fangyong;
Cartmel, Brenda;
Zhao, Julian;
Sanft, Tara;
Lisevick, Alexa;
Winer, Eric P.;
Lustberg, Maryam;
Spiegelman, Donna;
Sharifi, Mona;
Irwin, Melinda L.;
Ferrucci, Leah M.

Publication type:

Article

ERα/PR crosstalk is altered in the context of the ERα Y537S mutation and contributes to endocrine therapy-resistant tumor proliferation.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00601-7

By:

Huggins, Rosemary J.;
Greene, Geoffrey L.

Publication type:

Article

Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00604-4

By:

Beumers, Lukas;
Vlachavas, Efstathios-Iason;
Borgoni, Simone;
Schwarzmüller, Luisa;
Penso-Dolfin, Luca;
Michels, Birgitta E.;
Sofyali, Emre;
Burmester, Sara;
Heiss, Daniela;
Wilhelm, Heike;
Yarden, Yosef;
Helm, Dominic;
Will, Rainer;
Goncalves, Angela;
Wiemann, Stefan

Publication type:

Article

Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancer.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00591-6

By:

Chadha, M.;
White, J.;
Swain, S. M.;
Rakovitch, E.;
Jagsi, R.;
Whelan, T.;
Sparano, J. A.

Publication type:

Article

Endoxifen downregulates AKT phosphorylation through protein kinase C beta 1 inhibition in ERα+ breast cancer.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00606-2

By:

Jayaraman, Swaathi;
Wu, Xinyan;
Kalari, Krishna R.;
Tang, Xiaojia;
Kuffel, Mary J.;
Bruinsma, Elizabeth S.;
Jalali, Shahrzad;
Peterson, Kevin L.;
Correia, Cristina;
Kudgus, Rachel A.;
Kaufmann, Scott H.;
Renuse, Santosh;
Ingle, James N.;
Reid, Joel M.;
Ames, Matthew M.;
Fields, Alan P.;
Schellenberg, Matthew J.;
Hawse, John R.;
Pandey, Akhilesh;
Goetz, Matthew P.

Publication type:

Article

Histopathological growth patterns and tumor-infiltrating lymphocytes in breast cancer liver metastases.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00602-6

By:

Leduc, Sophia;
De Schepper, Maxim;
Richard, François;
Maetens, Marion;
Pabba, Anirudh;
Borremans, Kristien;
Jaekers, Joris;
Latacz, Emily;
Zels, Gitte;
Bohlok, Ali;
Van Baelen, Karen;
Nguyen, Ha Linh;
Geukens, Tatjana;
Dirix, Luc;
Larsimont, Denis;
Vankerckhove, Sophie;
Santos, Eva;
Oliveira, Rui Caetano;
Dede, Kristòf;
Kulka, Janina

Publication type:

Article

Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00600-8

By:

Vidarsdottir, Linda;
Olafsdottir, Elinborg J.;
Barkardottir, Rosa B.;
Bjarnadottir, Olöf;
Jonasson, Jon G.;
Sigurdsson, Stefan;
Tryggvadottir, Laufey

Publication type:

Article

Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.

Published in:

2023

By:

Fabi, Alessandra;
Carbognin, Luisa;
Botticelli, Andrea;
Paris, Ida;
Fuso, Paolo;
Savastano, Maria Cristina;
La Verde, Nicla;
Strina, Carla;
Pedersini, Rebecca;
Guarino, Stefania;
Curigliano, Giuseppe;
Criscitiello, Carmen;
Raffaele, Mimma;
Beano, Alessandra;
Franco, Antonio;
Valerio, Maria Rosaria;
Verderame, Francesco;
Fontana, Andrea;
Haspinger, Eva Regina;
Caldara, Alessia

Publication type:

Correction Notice

PI3K/AKT signaling activates HIF1α to modulate the biological effects of invasive breast cancer with microcalcification.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00598-z

By:

Tian, Yao;
Zhao, Lu;
Gui, Zhengwei;
Liu, Shiyang;
Liu, Chenguang;
Yu, Tianyao;
Zhang, Lin

Publication type:

Article

Predicting early breast cancer recurrence from histopathological images in the Carolina Breast Cancer Study.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00597-0

By:

Shi, Yifeng;
Olsson, Linnea T.;
Hoadley, Katherine A.;
Calhoun, Benjamin C.;
Marron, J. S.;
Geradts, Joseph;
Niethammer, Marc;
Troester, Melissa A.

Publication type:

Article

Prediction models for hormone receptor status in female breast cancer do not extend to males: further evidence of sex-based disparity in breast cancer.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00599-y

By:

Chatterji, Subarnarekha;
Niehues, Jan Moritz;
van Treeck, Marko;
Loeffler, Chiara Maria Lavinia;
Saldanha, Oliver Lester;
Veldhuizen, Gregory Patrick;
Cifci, Didem;
Carrero, Zunamys Itzell;
Abu-Eid, Rasha;
Speirs, Valerie;
Kather, Jakob Nikolas

Publication type:

Article

Effects of socioeconomic status and race on survival and treatment in metastatic breast cancer.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00595-2

By:

Puthanmadhom Narayanan, Susrutha;
Ren, Dianxu;
Oesterreich, Steffi;
Lee, Adrian V.;
Rosenzweig, Margaret Q.;
Brufsky, Adam M.

Publication type:

Article

Pertuzumab plus high-dose trastuzumab for HER2-positive breast cancer with brain metastases: PATRICIA final efficacy data.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00587-2

By:

Lin, Nancy U.;
Kumthekar, Priya;
Sahebjam, Solmaz;
Ibrahim, Nuhad;
Fung, Anita;
Cheng, Anna;
Nicholas, Alan;
Sussell, Jesse;
Pegram, Mark

Publication type:

Article

Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00594-3

By:

Record, Helena;
Clelland, Elle;
Rothschild, Harriet T.;
Kaur, Mandeep;
Chien, A. Jo;
Melisko, Michelle;
Rugo, Hope S.;
Mujir, Firdows;
Huppert, Laura;
Mukhtar, Rita A.

Publication type:

Article

Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristics.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00585-4

By:

Gamble, Lauren A.;
McClelland, Paul H.;
Teke, Martha E.;
Samaranayake, Sarah G.;
Juneau, Paul;
Famiglietti, Amber L.;
Blakely, Andrew M.;
Redd, Bernadette;
Davis, Jeremy L.

Publication type:

Article

Adipose-enriched peri-tumoral stroma, in contrast to myofibroblast-enriched stroma, prognosticates poorer survival in breast cancers.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00590-7

By:

Lau, Hannah Si Hui;
Tan, Veronique Kiak Mien;
Tan, Benita Kiat Tee;
Sim, Yirong;
Quist, Jelmar;
Thike, Aye Aye;
Tan, Puay Hoon;
Pervaiz, Shazib;
Grigoriadis, Anita;
Sabapathy, Kanaga

Publication type:

Article

Author Correction: Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristics.

Published in:

2023

By:

Gamble, Lauren A.;
McClelland, Paul H.;
Teke, Martha E.;
Samaranayake, Sarah G.;
Juneau, Paul;
Famiglietti, Amber L.;
Blakely, Andrew M.;
Redd, Bernadette;
Davis, Jeremy L.

Publication type:

Correction Notice

Incidence of HER2-expressing brain metastases in patients with HER2-null breast cancer: a matched case analysis.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00592-5

By:

Moss, Nelson S.;
Singh, Jolene M.;
Reiner, Anne S.;
Drago, Joshua Z.;
Modi, Shanu;
Seidman, Andrew D.;
Chandarlapaty, Sarat;
Ross, Dara S.

Publication type:

Article

TRIM21 mediates the synergistic effect of Olaparib and Sorafenib by degrading BRCA1 through ubiquitination in TNBC.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00588-1

By:

Huang, Ning;
Li, Peng;
Sun, Xiaolin;
Tong, Li;
Dong, Xinyi;
Zhang, Xuemei;
Duan, Jifeng;
Sheng, Xia;
Xin, Hong

Publication type:

Article

Perturbation and stability of PAM50 subtyping in population-based primary invasive breast cancer.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00589-0

By:

Veerla, Srinivas;
Hohmann, Lennart;
Nacer, Deborah F.;
Vallon-Christersson, Johan;
Staaf, Johan

Publication type:

Article

Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM).

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00584-5

By:

Niikura, Naoki;
Yamanaka, Takashi;
Nomura, Hironori;
Shiraishi, Kazuhiro;
Kusama, Hiroki;
Yamamoto, Mitsugu;
Matsuura, Kazuo;
Inoue, Kenichi;
Takahara, Sachiko;
Kita, Shosuke;
Yamaguchi, Miki;
Aruga, Tomoyuki;
Shibata, Nobuhiro;
Shimomura, Akihiko;
Ozaki, Yuri;
Sakai, Shuji;
Kiga, Yoko;
Izutani, Tadahiro;
Shiosakai, Kazuhito;
Tsurutani, Junji

Publication type:

Article

Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00572-9

By:

Cosgrove, Nicola;
Eustace, Alex J.;
O'Donovan, Peter;
Madden, Stephen F.;
Moran, Bruce;
Crown, John;
Moulton, Brian;
Morris, Patrick G.;
Grogan, Liam;
Breathnach, Oscar;
Power, Colm;
Allen, Michael;
Walshe, Janice M.;
Hill, Arnold D.;
Blümel, Anna;
O'Connor, Darren;
Das, Sudipto;
Milewska, Małgorzata;
Fay, Joanna;
Kay, Elaine

Publication type:

Article

Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00583-6

By:

Ladan, Marjolijn M.;
Meijer, Titia G.;
Verkaik, Nicole S.;
de Monye, Cecile;
Koppert, Linetta B.;
Oomen-de Hoop, Esther;
van Deurzen, Carolien H. M.;
Kanaar, Roland;
Nonnekens, Julie;
van Gent, Dik C.;
Jager, Agnes

Publication type:

Article

Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes—exploratory analysis of the Clalit registry.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00586-3

By:

Shachar, Shlomit S.;
Leviov, Michelle;
Yerushalmi, Rinat;
Drumea, Karen;
Tokar, Margarita;
Soussan-Gutman, Lior;
Bareket-Samish, Avital;
Sonnenblick, Amir;
Ben-Baruch, Noa;
Evron, Ella;
Gal-Yam, Einav Nili;
Paluch-Shimon, Shani;
Bar-Sela, Gil;
Goldvaser, Hadar;
Stemmer, Salomon M.

Publication type:

Article

Multidimensional quantitative phenotypic and molecular analysis reveals neomorphic behaviors of p53 missense mutants.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00582-7

By:

Pal, Anasuya;
Gonzalez-Malerva, Laura;
Eaton, Seron;
Xu, Chenxi;
Zhang, Yining;
Grief, Dustin;
Sakala, Lydia;
Nwekwo, Lilian;
Zeng, Jia;
Christensen, Grant;
Gupta, Chitrak;
Streitwieser, Ellen;
Singharoy, Abhishek;
Park, Jin G.;
LaBaer, Joshua

Publication type:

Article

Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristics.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00585-4

By:

Gamble, Lauren A.;
McClelland, Paul H.;
Teke, Martha E.;
Samaranayake, Sarah G.;
Juneau, Paul;
Famiglietti, Amber L.;
Blakely, Andrew M.;
Redd, Bernadette;
Davis, Jeremy L.

Publication type:

Article

Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00561-y

By:

Turner, Nicholas C.;
Laird, A. Douglas;
Telli, Melinda L.;
Rugo, Hope S.;
Mailliez, Audrey;
Ettl, Johannes;
Grischke, Eva-Maria;
Mina, Lida A.;
Balmaña, Judith;
Fasching, Peter A.;
Hurvitz, Sara A.;
Hopkins, Julia F.;
Albacker, Lee A.;
Chelliserry, Jijumon;
Chen, Ying;
Conte, Umberto;
Wardley, Andrew M.;
Robson, Mark E.

Publication type:

Article

Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.

Published in:

2023

By:

Hopcroft, Lorna;
Wigmore, Eleanor M.;
Williamson, Stuart C.;
Ros, Susana;
Eberlein, Cath;
Moss, Jennifer I.;
Urosevic, Jelena;
Carnevalli, Larissa S.;
Talbot, Sara;
Bradshaw, Lauren;
Blaker, Catherine;
Gunda, Sreeharsha;
Owenson, Venetia;
Hoffmann, Scott;
Sutton, Daniel;
Jones, Stewart;
Goodwin, Richard J. A.;
Willis, Brandon S.;
Rooney, Claire;
de Bruin, Elza C.

Publication type:

Correction Notice

High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00580-9

By:

Vliek, Sonja;
Hilbers, Florentine S.;
van Werkhoven, Erik;
Mandjes, Ingrid;
Kessels, Rob;
Kleiterp, Sieta;
Lips, Esther H.;
Mulder, Lennart;
Kayembe, Mutamba T.;
Loo, Claudette E.;
Russell, Nicola S.;
Vrancken Peeters, Marie-Jeanne T. F. D.;
Holtkamp, Marjo J.;
Schot, Margaret;
Baars, Joke W.;
Honkoop, Aafke H.;
Vulink, Annelie J. E.;
Imholz, Alex L. T.;
Vrijaldenhoven, Suzan;
van den Berkmortel, Franchette W. P. J.

Publication type:

Article

Deep learning model improves tumor-infiltrating lymphocyte evaluation and therapeutic response prediction in breast cancer.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00577-4

By:

Choi, Sangjoon;
Cho, Soo Ick;
Jung, Wonkyung;
Lee, Taebum;
Choi, Su Jin;
Song, Sanghoon;
Park, Gahee;
Park, Seonwook;
Ma, Minuk;
Pereira, Sérgio;
Yoo, Donggeun;
Shin, Seunghwan;
Ock, Chan-Young;
Kim, Seokhwi

Publication type:

Article

Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00571-w

By:

Hopcroft, Lorna;
Wigmore, Eleanor M.;
Williamson, Stuart C.;
Ros, Susana;
Eberlein, Cath;
Moss, Jennifer I.;
Urosevic, Jelena;
Carnevalli, Larissa S.;
Talbot, Sara;
Bradshaw, Lauren;
Blaker, Catherine;
Gunda, Sreeharsha;
Owenson, Venetia;
Hoffmann, Scott;
Sutton, Daniel;
Jones, Stewart;
Goodwin, Richard J. A.;
Willis, Brandon S.;
Rooney, Claire;
DeBruin, Elza

Publication type:

Article

Emerging systemic therapy options beyond CDK4/6 inhibitors for hormone receptor-positive HER2-negative advanced breast cancer.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00578-3

By:

Ma, Jun;
Chan, Jack Junjie;
Toh, Ching Han;
Yap, Yoon-Sim

Publication type:

Article

Adverse kidney outcomes of CDK 4/6 inhibitors for metastatic breast cancer.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00576-5

By:

Hanna, Paul E.;
Strohbehn, Ian A.;
Moreno, Daiana;
Harden, Destiny;
Seethapathy, Rituvanthikaa;
Sawtell, Rani;
Wang, Qiyu;
Ouyang, Tianqi;
Katz-Agranov, Nurit;
Dinulos, James;
Wander, Seth A.;
Gupta, Shruti;
Sise, Meghan E.

Publication type:

Article

Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00579-2

By:

Fabi, Alessandra;
Carbognin, Luisa;
Botticelli, Andrea;
Paris, Ida;
Fuso, Paolo;
Savastano, Maria Cristina;
La Verde, Nicla;
Strina, Carla;
Pedersini, Rebecca;
Guarino, Stefania;
Curigliano, Giuseppe;
Criscitiello, Carmen;
Raffaele, Mimma;
Beano, Alessandra;
Franco, Antonio;
Valerio, Maria Rosaria;
Verderame, Francesco;
Fontana, Andrea;
Haspinger, Eva Regina;
Caldara, Alessia

Publication type:

Article

Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.

Published in:

2023

By:

Hopcroft, Lorna;
Wigmore, Eleanor M.;
Williamson, Stuart C.;
Ros, Susana;
Eberlein, Cath;
Moss, Jennifer I.;
Urosevic, Jelena;
Carnevalli, Larissa S.;
Talbot, Sara;
Bradshaw, Lauren;
Blaker, Catherine;
Gunda, Sreeharsha;
Owenson, Venetia;
Hoffmann, Scott;
Sutton, Daniel;
Jones, Stewart;
Goodwin, Richard J. A.;
Willis, Brandon S.;
Rooney, Claire;
DeBruin, Elza

Publication type:

Correction Notice

Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00568-5

By:

Teo, Zhi Ling;
O'Connor, Mark J.;
Versaci, Stephanie;
Clarke, Kylie A.;
Brown, Emmaline R.;
Percy, Luke W.;
Kuykhoven, Keilly;
Mintoff, Christopher P.;
Savas, Peter;
Virassamy, Balaji;
Luen, Stephen J.;
Byrne, Ann;
Sant, Sneha;
Lindeman, Geoffrey J.;
Darcy, Phillip K.;
Loi, Sherene

Publication type:

Article

Radiomic predicts early response to CDK4/6 inhibitors in hormone receptor positive metastatic breast cancer.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00574-7

By:

Khorrami, Mohammadhadi;
Viswanathan, Vidya Sakar;
Reddy, Priyanka;
Braman, Nathaniel;
Kunte, Siddharth;
Gupta, Amit;
Abraham, Jame;
Montero, Alberto J.;
Madabhushi, Anant

Publication type:

Article

Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00573-8

By:

Zhao, Ming;
DiPeri, Timothy P.;
Raso, Maria Gabriela;
Zheng, Xiaofeng;
Rizvi, Yasmeen Qamar;
Evans, Kurt W.;
Yang, Fei;
Akcakanat, Argun;
Roberto Estecio, Marco;
Tripathy, Debu;
Dumbrava, Ecaterina E.;
Damodaran, Senthil;
Meric-Bernstam, Funda

Publication type:

Article

Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00579-2

By:

Fabi, Alessandra;
Carbognin, Luisa;
Botticelli, Andrea;
Paris, Ida;
Fuso, Paola;
Savastano, Maria Cristina;
La Verde, Nicla;
Strina, Carla;
Pedersini, Rebecca;
Guarino, Stefania;
Curigliano, Giuseppe;
Criscitiello, Carmen;
Raffaele, Mimma;
Beano, Alessandra;
Franco, Antonio;
Valerio, Maria Rosaria;
Verderame, Francesco;
Fontana, Andrea;
Haspinger, Eva Regina;
Caldara, Alessia

Publication type:

Article

Impact of a risk based breast screening decision aid on understanding, acceptance and decision making.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00569-4

By:

Lippey, Jocelyn;
Keogh, Louise;
Campbell, Ian;
Mann, Gregory Bruce;
Forrest, Laura Elenor

Publication type:

Article

RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00564-9

By:

Magna, Melinda;
Hwang, Gyong Ha;
McIntosh, Alec;
Drews-Elger, Katherine;
Takabatake, Masaru;
Ikeda, Adam;
Mera, Barbara J.;
Kwak, Taekyoung;
Miller, Philip;
Lippman, Marc E.;
Hudson, Barry I.

Publication type:

Article

CBD-oil as a potential solution in case of severe tamoxifen-related side effects.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00570-x

By:

Buijs, Sanne M.;
Braal, C. Louwrens;
Buck, Stefan A. J.;
van Maanen, Noud F.;
van der Meijden-Erkelens, Lonneke M.;
Kuijper-Tissot van Patot, Heleen A.;
Hoop, Esther Oomen-de;
Saes, Lotte;
van den Boogerd, Sophia J.;
Struik, Liesbeth E. M.;
van Rossum-Schornagel, Quirine C.;
Mathijssen, Ron H. J.;
Koolen, Stijn L. W.;
Jager, Agnes

Publication type:

Article

Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survival.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00563-w

By:

Verschoor, Noortje;
de Weerd, Vanja;
Van, Mai N.;
Kraan, Jaco;
Smid, Marcel;
Heijns, Joan B.;
Drooger, Jan C.;
Zuetenhorst, Johanna M.;
van der Padt-Pruijsten, Annemieke;
Jager, Agnes;
Sleijfer, Stefan;
Martens, John W. M.;
Wilting, Saskia M.

Publication type:

Article

Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity?

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00566-7

By:

Yu, Jing;
da Silva, Edaise M.;
La, Hae-Sun;
Clark, Beth Z.;
Fine, Jeffrey L.;
Carter, Gloria J.;
Villatoro, Tatiana M.;
Soong, T. Rinda;
Lee, Adrian V.;
Oesterreich, Steffi;
Basili, Thais;
Blanco-Heredia, Juan;
Selenica, Pier;
Ye, Qiqi;
Da Cruz Paula, Arnaud;
Dopeso, Higinio;
Gazzo, Andrea;
Marra, Antonio;
Pareja, Fresia;
Reis-Filho, Jorge S.

Publication type:

Article

Author Correction: Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial.

Published in:

2023

By:

Yang, Yang;
He, Yingjian;
Fan, Zhaoqing;
Chen, Xue;
Liu, Yiqiang;
Zhang, Chao;
Jiang, Hongchuan;
Wang, Xin;
Wang, Xiang;
Xie, Fei;
Wang, Shu;
Luo, Bin;
Kang, Hua;
Wang, Tao;
Jiang, Zefei;
Yuan, Peng;
Xu, Binhe;
Xu, Ling;
Liu, Yinhua;
Li, Jinfeng

Publication type:

Correction Notice

Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00571-w

By:

Hopcroft, Lorna;
Wigmore, Eleanor M.;
Williamson, Stuart C.;
Ros, Susana;
Eberlein, Cath;
Moss, Jennifer I.;
Urosevic, Jelena;
Carnevalli, Larissa S.;
Talbot, Sara;
Bradshaw, Lauren;
Blaker, Catherine;
Gunda, Sreeharsha;
Owenson, Venetia;
Hoffman, Scott;
Sutton, Daniel;
Jones, Stewart;
Goodwin, Richard J. A.;
Willis, Brandon S.;
Rooney, Claire;
DeBruin, Elza

Publication type:

Article

Multi-center study on predicting breast cancer lymph node status from core needle biopsy specimens using multi-modal and multi-instance deep learning.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00562-x

By:

Ding, Yan;
Yang, Fan;
Han, Mengxue;
Li, Chunhui;
Wang, Yanan;
Xu, Xin;
Zhao, Min;
Zhao, Meng;
Yue, Meng;
Deng, Huiyan;
Yang, Huichai;
Yao, Jianhua;
Liu, Yueping

Publication type:

Article

Spatial immunophenotypes orchestrate prognosis in triple-negative breast cancer with Miller-Payne grade 4 following neoadjuvant chemotherapy.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00565-8

By:

Ma, Jianli;
Deng, Yuwei;
Chen, Dawei;
Li, Xiaomei;
Yu, Zhiyong;
Wang, Haibo;
Zhong, Lei;
Li, Yingjie;
Wang, Chengqin;
Li, Xiang;
Yu, Jinming;
Zhang, Qingyuan

Publication type:

Article

Incorporating clinicopathological and molecular risk prediction tools to improve outcomes in early HR+/HER2– breast cancer.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00560-z

By:

Curigliano, Giuseppe;
Dent, Rebecca;
Llombart-Cussac, Antonio;
Pegram, Mark;
Pusztai, Lajos;
Turner, Nicholas;
Viale, Giuseppe

Publication type:

Article

Rare subtypes of triple negative breast cancer: Current understanding and future directions.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00554-x

By:

Thomas, Alexandra;
Reis-Filho, Jorge S.;
Geyer Jr, Charles E.;
Wen, Hannah Y.

Publication type:

Article